Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome

R. Scott Lucidi, Angela C. Thyer, Carol A. Easton, Alan E.C. Holden, Robert S. Schenken, Robert G. Brzyski

Research output: Contribution to journalArticle

29 Scopus citations


In women with polycystic ovary syndrome, chromium picolinate (200 μg/d) improves glucose tolerance compared with placebo but does not improve ovulatory frequency or hormonal parameters. This pilot study indicates that future studies in the polycystic ovary syndrome population should examine higher dosages or longer durations of treatment.

Original languageEnglish (US)
Pages (from-to)1755-1757
Number of pages3
JournalFertility and Sterility
Issue number6
StatePublished - Dec 1 2005


ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this